logo BDSP

Base documentaire

  1. A cost analysis on the pattern of asthma prescribing in the UK.

    Article - En anglais

    There is a need to establish the proportion of adult asthmatics at each step of the recommended asthma management guidelines, the cost of their prescribed treatment, and a revised cost of treatment assuming patients who were suboptimally controlled were moved up a step.

    Actual prescription and cost figures and a theoretical projection of an ideal scenario was calculated from a sample of general practices in Great Britain from the Doctors Independent Network.

    They comprised 102 nationally distributed practices and 17,206 adult patients with a diagnosis of, and prescription related to, asthma recorded between October 1993 and March 1994.

    Ninety-one per cent of patients received treatment within a recognized step of the guidelines.

    Of these, 80% were at steps 1 and 2. Employing excess inhaled beta-agonist use as a proxy for control of asthma, between 55% and 69% of patients at Steps 1-3 should receive treatment at a higher step.

    This could lead to an increased expenditure of up to £4.66 per adult patient per month.

    This would imply a rise in the annual UK cost of antiasthma prescriptions for adults from £388m to a possible £533m.

    The United Kingdom Government audit commission has suggested that current expenditure on asthma treatment appears to be insufficient.

    Using an entirely different approach this study has confirmed that a significant increase in asthma prescribing costs is likely to be needed if optimal control of asthma is to be achieved.

    Mots-clés Pascal : Asthme, Traitement, Prescription médicale, Analyse coût, Estimation coût, Royaume Uni, Europe, Recommandation, Economie santé, Evolution, Homme, Appareil respiratoire pathologie, Bronchopneumopathie obstructive

    Mots-clés Pascal anglais : Asthma, Treatment, Medical prescription, Cost analysis, Cost estimation, United Kingdom, Europe, Recommendation, Health economy, Evolution, Human, Respiratory disease, Obstructive pulmonary disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0491008

    Code Inist : 002B11B. Création : 22/03/2000.